Melanotan II
Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH), a non-selective agonist across the melanocortin receptor family. It is one of the most widely studied synthetic melanocortin peptides, with research interest spanning pigmentation and libido-related pathways.
Mechanism
- MC1R agonism. Activates melanocortin-1 receptors on melanocytes, stimulating melanogenesis (melanin production) — the pathway underlying its pigmentation research use.
- MC4R agonism. Also activates melanocortin-4 receptors in the hypothalamus, a pathway studied in connection with sexual arousal and appetite regulation — the basis for related libido research and for the derivative peptide PT-141.
Common research protocols
Dosing information below reflects published research literature. It is not medical advice and is not a treatment plan.
- Route. Subcutaneous injection.
- Research context. Subcutaneous dosing is the standard route in pigmentation and libido-pathway research.
Evidence at a glance
- Regulatory status. Not FDA-approved. Investigational; its receptor-selective derivative PT-141 (Bremelanotide) has since received FDA approval for a specific indication, but Melanotan II itself has not.
- What we do not know. Long-term pigmentation-pathway safety data; cardiovascular and appetite effects at research dosing levels.
Reconstitution & handling
Lyophilized peptides ship as freeze-dried powder. Reconstitute with bacteriostatic water; refrigerate the reconstituted vial. Use the reconstitution calculator to get syringe-unit readings for your target dose. General reconstitution and syringe guidance in the How We Work page.
Primary-literature list for this guide available on request via contact.
Further reading — external professional sources
- Melanotan II — Wikipedia
- PubMed — search "Melanotan II"
- ClinicalTrials.gov — trials for "Melanotan II"